Pharmacological studies with N-3,4,5-trimethoxybenzoyl-heptamethylene imine (N-1157), a new antidepressant agent.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D001259:Ataxia / Q000517:prevention & control; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002375:Catalepsy / Q000517:prevention & control; D002415:Cats; D003864:Depression, Chemical; D004285:Dogs; D004357:Drug Synergism; D004562:Electrocardiography; D004924:Escape Reaction / Q000187:drug effects; D005260:Female; D006591:Hexobarbital / Q000494:pharmacology; D006801:Humans; D007099:Imipramine / Q000494:pharmacology*; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D009949:Orientation / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors*; D012119:Respiration / Q000187:drug effects; D013268:Stimulation, Chemical
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D012110:Reserpine; D006591:Hexobarbital; D000661:Amphetamine; D007099:Imipramine; D009526:Nialamide; D009638:Norepinephrine